Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
Variable intralesional immunotherapies have recently been proposed as a means of achieving a successful eradication of recurrent and recalcitrant human papillomavirus (HPV)-induced cutaneous and anogenital warts. The bivalent HPV vaccine is one of the newly proposed immunotherapeutic agents. We inve...
Saved in:
Main Authors: | Noha M. Hammad, Ayman Marei, Gamal El-Didamony, Zeinb Mortada, Mona Elradi, Amira Hamed Mohamed Afifi, Heba M. Kadry |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/985580161e3340b19bae725f2a5fa47c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare resource utilization and costs associated with anogenital warts in Morocco
by: Myriam Berrada, et al.
Published: (2021) -
Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination
by: Laila Khawar, MPH, et al.
Published: (2021) -
HPV-ASSOCIATED DISEASES IN THE STRUCTURE OF FEMALE REPRODUCTIVE TRACT TUMORS AND SEXUALLY TRANSMITTED INFECTIONS IN MOSCOW AND RUSSIA
by: N. I. Briko, et al.
Published: (2018) -
INTRALESIONAL BLEOMYCIN IN TREATMENT OF PLANTAR WARTS
by: Ayesha Khokhar, et al.
Published: (2019) -
Successful treatment of plantar warts with intralesional bleomycin and electroporation: pilot prospective study
by: Paola Pasquali, et al.
Published: (2017)